Actinium Pharmaceuticals reported 81K in Gross Profit on Sales for its fiscal quarter ending in December of 2023.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Actinium Pharmaceuticals 81K 36K Dec/2023
Amgen USD 5.87B 1.02B Mar/2026
Bioline Rx USD 382K 39K Mar/2026
Capricor Therapeutics 11.13M 8.87M Dec/2024
Pfizer USD -248M 11.29B Jun/2026